Lam WS

No ORCID on file · 3 papers in corpus
nonrandomized-trial 2025
JAMA oncology ·doi:10.1001/jamaoncol.2025.1916

IMPORTANCE: Gynecological clear cell cancers (CCCs) are aggressive malignant neoplasms with low response rate to chemotherapy. The treatment of patients with metastatic disease remains an area of significant unmet need. OBJECTIVE: To evalu…

meta-analysis 2016
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd001750.pub4

BACKGROUND: Gonadotrophin-releasing hormone (GnRH) antagonists can be used to prevent a luteinizing hormone (LH) surge during controlled ovarian hyperstimulation (COH) without the hypo-oestrogenic side-effects, flare-up, or long down-regula…

meta-analysis 2016
The Cochrane database of systematic reviews ·doi:10.1002/14651858.cd003719.pub4

BACKGROUND: For the last few decades urinary human chorionic gonadotrophin (uhCG) has been used to trigger final oocyte maturation in cycles of in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). Recombinant technology…